Cargando…
Preclinical investigation of patient-derived cervical cancer organoids for precision medicine
OBJECTIVE: Advanced cervical cancer is still difficult to treat and in the case of recurrent cancer, it is desirable to utilize personalized treatment rather than uniform treatment because the type of recurrence is different for each individual. Therefore, this study aimed to establish a patient-der...
Autores principales: | Seol, Hyang Sook, Oh, Ju Hee, Choi, Eunhye, Kim, SangMin, Kim, Hyunki, Nam, Eun Ji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157333/ https://www.ncbi.nlm.nih.gov/pubmed/36659831 http://dx.doi.org/10.3802/jgo.2023.34.e35 |
Ejemplares similares
-
Patient‐derived organoids as a preclinical platform for precision medicine in colorectal cancer
por: Cho, Young‐Won, et al.
Publicado: (2022) -
Lung cancer organoids: models for preclinical research and precision medicine
por: Liu, Yajing, et al.
Publicado: (2023) -
Moving toward precision medicine with lung cancer organoids
por: Kim, James, et al.
Publicado: (2023) -
Organoid modeling for cancer precision medicine
por: Cantrell, Michael A, et al.
Publicado: (2015) -
Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
por: Zhou, Zilong, et al.
Publicado: (2021)